John A. Neuwirth is a partner in the firm’s Securities Litigation practice group. Mr. Neuwirth’s practice focuses on the nationwide litigation of M&A, securities, derivative, complex business and corporate matters at the trial and appellate levels in both federal and state courts, and before arbitration panels. Mr. Neuwirth also counsels boards of directors, board committees and senior management on M&A, corporate governance, securities, disclosure, regulatory and other issues, and provides representation in connection with governmental, regulatory and internal investigations, and proxy contests. Clients he has represented include: ExxonMobil, General Electric, General Motors, Goldman Sachs, Citigroup, The Walt Disney Company, Maxim Integrated Products, Thomas H. Lee Partners, Providence Equity Partners, UnitedHealth, Gentiva Health Services, Sanofi and Safran S.A.
Mr. Neuwirth is listed in Chambers USA 2011 as one of America’s leading securities litigators and was also recognized in Benchmark Litigation 2012. In 2010, Mr. Neuwirth was named in Legal 500 as a leading securities litigator in the United States. In each of 2008, 2009, 2010 and 2011, Mr. Neuwirth was named a New York “SuperLawyer” in the securities litigation area. In 2007, The New York Times named Mr. Neuwirth one of the "faces of Wall Street's future...who make up the next generation of deal makers.” Also in 2007, Mr. Neuwirth was named by Securities Law 360 as one of "10 under 40" for his work in the securities litigation, corporate governance, class action and regulatory areas.
Mr. Neuwirth is a member of the firm's Nominating Committee and Professional Development Committee.